Most Recent

image: Detailing Color Vision

Detailing Color Vision

By | December 6, 2012

Scientists engineer a spectrum of artificial pigments to understand how animals see in color.

1 Comment

image: Hurry Up, FDA

Hurry Up, FDA

By | December 6, 2012

The US Food and Drug Administration is taking steps to get new devices on the market sooner—and antibiotics may be next.

0 Comments

image: MicroRNAs Repair Heart Cells

MicroRNAs Repair Heart Cells

By | December 5, 2012

Researchers identify microRNAs that keep cardiac cells healthy after heart attack, potentially paving the way for future heart regenerating therapies.

1 Comment

image: Marlboro Chicks

Marlboro Chicks

By | December 5, 2012

Two species of songbirds pack their nests with scavenged cigarette butts that repel irksome parasites.

1 Comment

image: New Mental Health Manual

New Mental Health Manual

By | December 5, 2012

Amid controversy, the American Psychiatric Association has approved the fifth edition of its guidebook on mental disorders.

1 Comment

image: Special Review for H5N1 Grants?

Special Review for H5N1 Grants?

By | December 4, 2012

The National Institutes of Health reveals a controversial plan to regulate the funding of H5N1 research.

0 Comments

image: Stem Cells from Blood

Stem Cells from Blood

By | December 3, 2012

Researchers develop a practical technique for deriving stem cells from routine blood samples.  

0 Comments

image: An Epi Phenomenon

An Epi Phenomenon

By | December 1, 2012

While exploring the genetics of a rare type of tumor, Stephen Baylin discovered an epigenetic modification that occurs in most every cancer—a finding he’s helping bring to the clinic.

5 Comments

image: Contributors

Contributors

By | December 1, 2012

Meet some of the people featured in the December 2012 issue of The Scientist.

0 Comments

image: In the Long Run

In the Long Run

By | December 1, 2012

Can emulating our early human ancestors make us healthier?

1 Comment

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham